This article was reviewed by Felix Gussone, MD. Key Takeaways: Hormones play a major role in regulating metabolism, mood, energy, and reproductive health — and imbalances … ...

Hormones function as the body’s chemical messengers, orchestrating nearly every physiological process from metabolism and mood to reproduction and sleep. When these powerful compounds fall out of ...

Combining hormonal therapy and tirzepatide may lead to the greatest weight loss after menopause, new evidence suggests.

There’s no denying that modern life messes with our hormones. From stress to processed food to poor sleep, we’re constantly navigating internal chaos that leaves us tired, bloated, and moody. Good ...

Do you know what your hormone levels are? Should you? Your body is home to more than 50 hormones — chemical messengers that compose the endocrine system — and hormonal changes may reflect any number ...

If you’re a woman in your forties or fifties, you’re probably no stranger to the flood of advice and solutions flying at you from every corner of the internet about balancing your hormones. But what ...

In this MedPage Today interview, Rachel Weinerman, MD, a reproductive endocrinologist at Case Western Reserve University and University Hospitals in Cleveland, explains why menopause hormone therapy ...

Estrogen, progesterone, FSH, inhibin, and TSH are among the main hormones menopause affects. Hormone therapies and other natural strategies may help balance your levels. Menopause occurs when your ...

Hormone therapy is the gold standard for treating VMS, but requires careful patient selection and shared decision-making. Timing, dose, and formulation of hormone therapy are crucial for safety and ...

Some people may decide to stop taking hormone therapy for menopause symptoms because they no longer need it or they’re concerned about health risks. Stopping hormone therapy may cause symptoms to ...

This article originally appeared on Politifact. What does it mean when a warning label is removed from a medication after two decades? But the science wasn't so clear cut. The study that drove the ...

Novo Nordisk A/S (NYSE:NVO) on Monday presented data from the phase 3 REAL8 basket study investigating once-weekly Sogroya (somapacitan) in four different but related growth disorder indications, ...